Rosette-Forming Glioneuronal Tumor: Symptoms, Causes, Diagnosis and Treatment

Written by Medicover Team and Medically Reviewed by Dr Ganesh Krishna Murthy , Neurosurgeons

Causes
Find a Doctor
Diagnosis
Treatment
FAQs
Book an Appointment

1. Causes 2. Find a Doctor 3. Diagnosis 4. Treatment 5. FAQs

Rosette-forming glioneuronal tumor (RGNT) is a rare, slow-growing tumor of the central nervous system. It is classified as a World Health Organization (WHO) grade 1 tumor, meaning it is generally considered benign and has a favorable prognosis. RGNT most commonly develops in the fourth ventricle of the brain, although it can occur in other parts of the brain and spinal cord.

The tumor contains both glial and neuronal cells and often grows slowly over many years. Symptoms usually develop because the tumor compresses nearby brain structures or blocks the normal flow of cerebrospinal fluid, leading to increased pressure within the skull.

What Are the Types of Rosette-Forming Glioneuronal Tumor?

Rosette-forming glioneuronal tumor (RGNT) is not divided into recognised histological types or subtypes. However, it may occur in different locations within the central nervous system.

Fourth Ventricle RGNT: The most common location, arising in or around the fourth ventricle near the cerebellum and brainstem.
Extraventricular RGNT: Less commonly found in the cerebellum, brainstem, pineal region, spinal cord, optic pathway or cerebral hemispheres.

What Are the Symptoms of Rosette-Forming Glioneuronal Tumor?

Symptoms of Rosette-Forming Glioneuronal Tumor (RGNT) depend on the tumor's size and location. Because RGNT usually grows slowly, symptoms often develop gradually over months or even years.

Headaches: Often caused by increased pressure inside the skull.
Seizures: May occur, particularly if the tumor affects the cerebral hemispheres.
Balance and coordination problems: Difficulty walking or maintaining balance due to cerebellar involvement.
Nausea and vomiting: May develop because of increased intracranial pressure.
Vision changes: Blurred vision or double vision can occur if pressure affects the visual pathways.
Memory or cognitive changes: Some individuals may experience difficulty with concentration or memory.
Weakness or sensory changes: Weakness, numbness, or altered sensation may occur depending on the tumor's location.
Dizziness: Common when the tumor affects the brain's balance centers.

What Causes Rosette-Forming Glioneuronal Tumor?

The exact cause of RGNT remains unknown. Current evidence suggests that it develops because of acquired genetic changes in brain cells rather than inherited conditions.

Genetic Changes

Some tumors contain genetic alterations involving the FGFR1, PIK3CA, or PIK3R1 genes, which regulate cell growth and signalling pathways.

Abnormal Cell Growth

These genetic changes allow certain glial and neuronal precursor cells to grow abnormally, leading to tumor formation.

Unknown Risk Factors

Unlike many other cancers, no specific environmental or lifestyle factor has been proven to cause RGNT.

What Are the Complications of Rosette-Forming Glioneuronal Tumor?

Complications depend on the size, location and growth of the tumor.

Hydrocephalus caused by blockage of cerebrospinal fluid flow
Persistent headaches due to increased intracranial pressure
Balance and coordination problems
Vision disturbances
Neurological deficits affecting movement or sensation
Seizures
Tumor recurrence after treatment (uncommon but possible)
Complications related to surgery or radiation therapy

When to See a Doctor for Rosette-Forming Glioneuronal Tumor?

Medical evaluation by a Neurologist or Neurosurgeon is recommended if persistent headaches, balance problems, seizures, unexplained vision changes, or other progressive neurological symptoms develop. Early diagnosis allows timely treatment and helps prevent complications such as hydrocephalus and permanent neurological damage.

You should see a doctor if you have:

Persistent headaches that gradually worsen
Difficulty with balance, coordination or walking
New-onset seizures or progressive vision problems

Seek emergency medical care immediately if:

A seizure lasts longer than five minutes
There is sudden loss of consciousness or severe confusion
Severe headache occurs with repeated vomiting or sudden weakness

These symptoms may indicate increased pressure within the brain and require urgent medical attention.

Find Neurosurgeons for Rosette Forming Glioneuronal Tumor Treatment Near You

How Is Rosette-Forming Glioneuronal Tumor Diagnosed?

Diagnosis involves brain imaging followed by tissue examination to confirm the tumor type.

MRI Scan

MRI with gadolinium contrast is the preferred imaging technique because it provides detailed information about the tumor's size, location, internal characteristics and relationship to nearby brain structures, helping guide surgical planning.

CT Scan

A CT scan may help evaluate hydrocephalus or calcification within the tumor.

Biopsy and Histopathology

A biopsy or surgical specimen is examined under the microscope to confirm the diagnosis by identifying characteristic rosette formations and glioneuronal tissue.

Immunohistochemistry

Special laboratory staining helps distinguish RGNT from other brain tumors.

Molecular Testing

Genetic analysis may identify mutations such as FGFR1, PIK3CA or PIK3R1, which can support diagnosis and contribute to ongoing research.

How Is Rosette-Forming Glioneuronal Tumor Treated?

Treatment depends on the tumor's location, size, symptoms and whether it can be safely removed.

Surgery

Maximal safe surgical resection is the primary treatment. Gross total resection offers the best long-term outcome and is often curative when it can be achieved safely.

Observation

Small tumors causing few or no symptoms may be monitored with regular MRI scans rather than immediate treatment.

Radiation Therapy

Radiotherapy is not routinely required but may be considered for residual, recurrent or progressive tumors when further surgery is not feasible.

Chemotherapy

Chemotherapy is not routinely used because RGNT is generally a low-grade tumor. It may occasionally be considered in selected cases.

Supportive Treatment

Medications to control headaches
Anti-seizure medications if seizures occur
Treatment for hydrocephalus when necessary
Rehabilitation therapy for balance or neurological deficits

Your health is everything - prioritize your well-being today.

Consult Rosette Forming Glioneuronal Tumor Doctors Today

What Are the Risk Factors for Rosette-Forming Glioneuronal Tumor?

Because RGNT is extremely rare, few established risk factors have been identified.

Most commonly diagnosed in adolescents and young adults, although it can occur at any age
Slight female predominance has been reported
Acquired genetic mutations within tumor cells
No known inherited risk in most cases

Can Rosette-Forming Glioneuronal Tumor Be Prevented?

There are currently no known methods to prevent RGNT because its exact cause remains unknown. Maintaining overall health cannot eliminate the risk of developing this rare brain tumor.

Living With Rosette-Forming Glioneuronal Tumor

Because RGNT usually grows slowly and is classified as a WHO grade 1 tumor, long-term survival is generally excellent following successful treatment.

Most people with RGNT have an excellent long-term outlook after successful treatment. Regular follow-up MRI scans are recommended to monitor for recurrence, especially after partial tumor removal.

Individuals who experience neurological symptoms may benefit from physical therapy, occupational therapy or rehabilitation services. Ongoing care from neurosurgeons, neurologists and rehabilitation specialists helps optimise recovery and maintain quality of life.

Frequently Asked Questions

1. What is the prognosis for individuals with a rosette-forming glioneuronal tumor?

The prognosis varies depending on factors like the location and size of the tumor, age of the patient, and how well it responds to treatment. Regular follow-ups and imaging are essential to monitor any recurrence or progression.

2. What age do glioneuronal tumours occur?

Glioneuronal tumours can occur at any age but are more common in children and young adults. They are often slow-growing and may cause seizures. Early detection helps in better management and treatment outcomes.

3. Is a glioneuronal tumor benign or malignant?

Glioneuronal tumours are usually benign but can sometimes be low-grade malignant. Their behaviour depends on the subtype and location in the brain. Treatment options vary based on symptoms and tumour progression.

4. Which tumour is characteristic of rosette formation?

Medulloblastoma and ependymoma commonly show rosette formations. These distinctive structures help diagnose and classify brain tumours. Identifying rosette patterns aids in selecting the appropriate treatment approach.

5. What grade is a rosette-forming glioneuronal tumor?

Rosette-forming glioneuronal tumors are typically classified as Grade I by the WHO, indicating a slow-growing and less aggressive nature. They usually have a favourable prognosis with appropriate treatment.